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Abstract
Objective: To evaluate the hearing status of patients being treated for pulmonary tuberculosis at referral 
hospitals in Brazil. Methods: This was a descriptive study involving 97 male and female inpatients/outpatients 
between 18 and 60 years of age who were undergoing treatment for active pulmonary tuberculosis at one of 
two referral hospitals in the state of Rio de Janeiro. After being interviewed, all of the patients underwent pure 
tone audiometry. Results: Of the 97 patients studied, 65 (67%) were male, 52 (54%) were receiving first-line 
treatment, and 45 (46%) were receiving second-line treatment, which included aminoglycosides. Smoking, 
alcohol consumption, exposure to noise, and ototoxic medication use were identified in 65 (67%), 51 (53%), 
53 (55%), and 45 (46.4%) of the patients, respectively. The most common auditory and vestibular complaints 
were dizziness, in 28 patients (28.8%); tinnitus, in 27 (27.8%); and hypoacusis, in 23 (23.7%). Conclusions: 
Due to the great number of patients with hearing loss in the present study, we recommend that all patients 
with active pulmonary tuberculosis be submitted to auditory monitoring.
Keywords: Audiometry; Hearing loss; Tuberculosis; Drug toxicity.
Resumo
Objetivo: Analisar a condição auditiva de uma população em tratamento para tuberculose pulmonar em dois 
hospitais de referência no Brasil. Métodos: Estudo descritivo envolvendo 97 pacientes de ambos os sexos, com 
idade entre 18 anos e 60 anos, que estivessem em tratamento para tuberculose pulmonar ativa, internados ou 
em acompanhamento ambulatorial em dois hospitais de referência no estado do Rio de Janeiro. Os participantes 
foram entrevistados e realizaram audiometria tonal liminar. Resultados: Na população estudada, 65 pacientes 
(67%) eram homens, 52 (54%) estavam em tratamento de primeira linha e 45 (46%) estavam em tratamento 
de segunda linha, o qual incluía aminoglicosídeos. Tabagismo, uso de bebidas alcoólicas, exposição a ruído e 
uso de medicamentos ototóxicos foram identificados respectivamente em 65 (67%), 51 (53%), 53 (55%) e 45 
(46,4%) pacientes. As queixas auditivas e vestibulares mais frequentemente mencionadas foram tontura, em 28 
(28,8%); zumbido, em 27 (27,8%); e hipoacusia, em 23 (23,7%). Conclusões: Devido ao elevado número de 
casos de perda auditiva encontrado neste estudo, recomenda-se que todos os pacientes em tratamento para 
tuberculose sejam submetidos a monitoramento auditivo.
Descritores: Audiometria; Perda auditiva; Tuberculose; Toxicidade de drogas.
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Introduction
According to data from the World Health 
Organization, the incidence rate of tuberculosis 
continues to increase in Africa, in the Eastern 
Mediterranean region, and in Asia.(1) It is estimated 
that, in 2009, there were 9.4 million new cases 
of tuberculosis, 1.7 million deaths, and 500,000 
cases of multidrug-resistant tuberculosis (MDR-
TB) worldwide. The emergence of MDR-TB is a 
cause for concern, because these cases involve 
patients with strains of the tuberculosis bacillus 
that are resistant to the most effective drugs 
for the treatment of the disease (rifampin and 
isoniazid). In these situations, it is necessary 
to use second-line medications, which are less 
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years of age who had a low level of education, 
exhibited hearing loss classified as disabling. 
One group of authors evaluated tuberculosis 
patients receiving streptomycin and found that, 
in 75% of the cases, there was some type of 
hearing loss.(4)
The objective of the present study was to 
evaluate the hearing status of patients being 
treated for pulmonary tuberculosis at one of 
two referral hospitals for tuberculosis in the 
state of Rio de Janeiro, Brazil.
Methods
This was a descriptive study conducted between 
November and December of 2008 at two referral 
hospitals for tuberculosis in the state of Rio de 
Janeiro, Brazil: Instituto Estadual de Tórax Ary 
Parreiras and Hospital Estadual Santa Maria.
We included all inpatients/outpatients between 
18 and 60 years of age who were undergoing 
treatment for active pulmonary tuberculosis 
and who agreed to participate in the study. The 
volunteers gave written informed consent and 
responded to a standardized interview, followed by 
otoscopy for assessment of the internal acoustic 
meatus and tympanic membrane and by pure 
tone audiometry for determination of auditory 
thresholds.
We excluded patients who were not physically 
able to complete all stages of the study and 
those who declined to participate. Patients in 
whom the audiometric findings showed tracings 
consistent with changes or impairment of the 
external or middle ear were excluded from the 
analysis of the study.
The tests were performed in a 
portable soundproof booth with an Amplaid 
460 A audiometer (Amplifon S.p.A, Milan, Italy) 
and TDH-39 headphones (Telephonics Corporation, 
Farmingdale, NY, USA). All tests were performed 
by only one trained technician. The limit of 
normality was defined as a maximum intensity 
of 25 dB for all frequencies. When one or more 
frequencies showed values equal to or greater 
than 30 dB, the test was considered abnormal, 
even if unilaterally.(11)
Although the objectives of this study did 
not include determining the causal factor of the 
hearing impairment, we performed a statistical 
analysis to investigate a potential association 
between the variables of interest (smoking, alcohol 
consumption, ototoxic medication use, gender, 
effective, are associated with higher failure and 
mortality rates, and can increase the occurrence 
of adverse (gastrointestinal, hepatotoxic, ototoxic, 
etc) effects.
Brazil ranks 19th among the 22 countries with 
the highest tuberculosis burden worldwide. A World 
Health Organization report on tuberculosis in 
Brazil estimated that, in 2009, there were 92,000 
cases. A cohort study conducted between 2000 
and 2007 reported 2,690 cases of MDR-TB, 14% 
of which died. The treatment of MDR-TB lasts 
18 to 24 months and consists of an alternative 
pharmacological regimen, made available by the 
Brazilian National Ministry of Health and consisting 
of a combination of drugs, which is based on 
sensitivity testing results.(2) Among the medications 
used in special regimens and in regimens for 
MDR-TB, aminoglycosides (streptomycin and 
amikacin) are of note because of their ototoxic 
potential.(1)
Aminoglycosides can cause great damage to 
the cochlear or labyrinthine hair cells, causing 
permanent hearing losses and labyrinthine lesions.
(3,4) The lesion caused by ototoxic medication use 
can lead to different degrees of neurosensory 
hearing loss. This type of loss is characterized by 
being irreversible, i.e., it is not possible to return 
to previous auditory thresholds even after the 
medication is discontinued. The variation in the 
degree of loss depends on various factors, such as 
medication type/dose and genetic predisposition. 
In these situations, it is recommended that the 
drug be discontinued and replaced.(1)
In the international literature, the rates of 
ototoxicity as an adverse reaction to aminoglycoside 
use vary greatly (5-64%), since they depend on 
various factors, such as medication type/dose, 
duration of use, patient age, comorbidities, 
genetic predisposition, alcohol abuse, smoking, 
and living/working conditions (homeless individuals 
or construction workers, who are exposed to 
environmental noise), as well as on the diversity 
in the design of the studies in which these factors 
are described.(3-8)
In Brazil, there have been few studies on 
the hearing status of the general population 
and of patients with tuberculosis.(9,10) Hearing 
loss prevalence and psychosocial impairments 
(occupational difficulties, isolation, reduced 
quality of life, and depression) were reported 
in one study, in which 6.8% of the population, 
most of whom were low-income males over 60 
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common auditory and vestibular complaints were 
dizziness, in 28 patients (28.8%); tinnitus, in 27 
(27.8%); and difficulty in hearing (hypoacusis), 
in 23 (23.7%); Figure 1).
Group 1 comprised 54 patients (median 
age = 32 years; IQR: 27-36 years), whereas group 
2 comprised 43 patients (median age = 51 years; 
IQR: 47-56 years).
Abnormal audiometric findings (irreversible 
hearing loss) were more common in group 2 than 
in group 1, being observed in 30 (69.7%) and 24 
(44.4%) of the 43 and 54 patients, respectively 
(p = 0.02; OR = 2.8; 95% CI: 1.15-7.35). The 
auditory abnormalities were of varying degrees, 
ranging from mild to severe loss, and a common 
characteristic to all of the results was worse 
auditory thresholds at high frequencies (Figure 2).
In group 1, we found a statistically significant 
association between abnormal audiometric findings 
and exposure to ototoxic medications (p = 0.03). 
In group 2, abnormal audiometric findings were 
associated with male gender (p = 0.001) and 
smoking (p = 0.028; Table 1).
Discussion
Ototoxicity can cause, in addition to balance 
disturbances, varying degrees of permanent 
hearing loss. The frequencies responsible for 
speech discrimination are usually the last to 
be affected, and this can prevent patients from 
noticing their hearing loss promptly.(3) With 
audiometric evaluations, timely identification of 
hearing loss is possible, which allows appropriate 
interventions.
Although audiometric abnormalities were 
more common in the population over 40 years 
of age (69%), they were also quite common in 
those under 40 (44%). The damages caused by 
acquired hearing loss are many and result from 
and exposure to noise) and the audiometric 
findings. The patients were divided into two 
groups: patients aged 18 to 40 years (group 1) 
and patients aged 41 to 60 years (group 2). 
The evaluation was performed using two age 
groups to prevent age from being a confounding 
factor, since the auditory losses resulting from 
advancing age affect most of the population 
and show the same audiometric tracing as that 
of the variables studied.(3)
For categorical variables, percentage 
distribution was used. The Mann-Whitney test 
was used for evaluating the two groups, and, 
when this test was not applicable, Fisher’s exact 
test was used. The analyses were performed with 
the Epi Info statistical package, version 3.5.1. 
Values of p < 0.05 were considered statistically 
significant.
The study protocol was analyzed and approved 
by the Medical Ethics Committee of the Federal 
University of Rio de Janeiro Clementino Fraga 
Filho University Hospital (Protocol no. 065/07).
Results
We evaluated 114 subjects, 17 of whom were 
excluded from the statistical analysis because 
of the type of audiometric curve found (mixed 
or conductive—losses that have conductive 
components and are therefore inconsistent with 
the variables studied). Therefore, we included 
97 patients who either had normal audiometric 
findings or had neurosensory hearing loss. Of 
those 97 patients, 52 were receiving first-line 
treatment and 45 were receiving second-line 
treatment, which included aminoglycosides.
Previous aminoglycoside use was reported by 
27 (27.8%) of the 97 patients included in the 
study. Ototoxic medication use was observed in 
45 patients, streptomycin and amikacin being 
used by 11 and 34 patients, respectively. The 
use of these medications for at least 15 days 
was identified in 43 cases. Statistical analysis 
of this variable by type of medication was not 
performed because of the small sample size.
Regarding gender, 65 patients (67%) were 
male, with a median age of 40 years (interquartile 
range [IQR]: 33-52 years) and 32 (33%) were 
female, with a median age of 38 years (IQR: 26-42 
years). Smoking, alcohol consumption, exposure 
to noise, and use of ototoxic medication were 
identified in 65 (67%), 51 (53%), 53 (55%), and 
45 (46%) of the patients, respectively. The most 
Figure 1 - Distribution of auditory and vestibular 
complaints in group 1 (patients aged 18 to 40 years) 
and in group 2 (patients aged 41 to 60 years).
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the auditory sensitivity initially in the higher 
frequencies, which are decoded in the basal region 
of the cochlea.(3) Hearing damage caused by 
aminoglycoside use or by any of the variables 
analyzed in the present study has an audiometric 
configuration similar to that of presbycusis, and, 
therefore, age could present as a confounding 
factor. Although the older population had a high 
frequency of auditory complaints, there was no 
significant association between age and hearing 
loss. It should be borne in mind that the older 
communication impairment. Auditory or vestibular 
symptoms, such as tinnitus, dizziness, or even 
reports of slight difficulty in hearing, should be 
taken into consideration by the professionals 
involved. Therefore, appropriate referral can take 
place in order to preserve the sense of hearing 
and the balance of the population treated.
The choice to analyze two distinct age groups 
was based on previous studies on presbycusis,(3,10) 
i.e., increased auditory thresholds resulting from 
advancing age. The aging process can affect 
Table 1 - Statistical analysis of risk variables for hearing loss by pure tone audiometry findings in the study 
groups.
Variable Abnormal 
audiometry 
findings
Normal 
audiometry 
findings
Total OR (95% CI) p*
n % n % n %
Group 1 (18-40 years of age)
Gender
Female 7 30.4 16 69.6 23 100.0 0.36 (0.10-1.18) 0.077
Male 17 54.8 14 45.2 31 100.0
Smoking
Yes 15 46.9 17 53.1 32 100.0 1.27 (0.37-4.42) 0.061
No 9 40.9 13 59.1 22 100.0
Alcohol consumption
Yes 15 57.7 11 42.3 26 100.0 2.88 (0.83-10.26) 0.061
No 9 32.1 19 67.9 28 100.0
Exposure to noise
Yes 13 46.4 15 53.6 28 100.0 1.18 (0.35-3.99) 0.763
No 11 42.3 15 57.7 26 100.0
Ototoxic medication use
Yes 15 60.0 10 40.0 25 100.0 3.33 (0.95-12.7) 0.034
No 9 31.0 20 69.0 29 100.0
Group 2 (41-60 years of age)
Gender
Female 2 33.3 7 66.7 9 100.0 0.06 (0.01-0.46) 0.001
Male 28 82.4 6 17.7 34 100.0
Smoking
Yes 26 78.8 7 21.2 33 100.0 5.57 (0.99-33.89) 0.021
No 4 40.0 6 60.0 10 100.0
Alcohol consumption
Yes 19 76.0 6 24.0 25 100.0 0.02 (0.45-9.26) 0.300
No 11 61.1 7 38.9 18 100.0
Exposure to noise
Yes 18 72.0 7 28.0 25 100.0 1.29 (0.29-5.79) 0.710
No 12 66.7 6 33.3 18 100.0
Ototoxic medication use
Yes 14 70.0 6 30.0 20 100.0 1.02 (0.23-4.56) 0.976
No 16 69.6 7 30.4 23 100.0
*Mantel-Haenszel chi-square test or Fisher’s exact test when the chi-square test was not applicable.
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Typically, causal studies on ototoxicity should 
be longitudinal, and auditory thresholds should 
preferably be determined prior to medication use. 
Although the objective of the present study was not 
to determine the cause of the hearing impairment 
in this population, we analyzed the data on the 
patients receiving ototoxic medications in the 
two groups. An association between abnormal 
audiometric findings (neurosensory hearing loss) 
and ototoxic medication use occurred only in 
group 1 (p = 0.034). Similar findings in younger 
populations have been described by some authors.
(5,6) Despite not having been investigated, the 
duration of exposure to smoking, noise, and 
alcohol is estimated to be shorter in group 1 
than in group 2, and, therefore, the association 
between auditory abnormalities and exposure 
to ototoxic medication in group 1, which was 
observed in our study, is more plausible. In contrast, 
we observed a significant association between 
smoking and audiometric abnormalities only 
in the patients in group 2, which is similar to 
the findings reported by some authors,(14,15) but 
different from the findings reported by others.(16) 
Although we did not quantify smoking history 
in our study, we estimate that there is a direct 
relationship between increasing age and smoking 
history. Habitual alcohol consumption was not 
related to audiometric abnormalities in either of 
the two groups studied. Although the relationship 
between hearing loss and alcohol consumption 
is not yet well established, some authors suggest 
this association.(17-19)
In conclusion, due to the great number of 
patients with permanent hearing loss in our 
sample, we suggest that patients undergoing 
antituberculosis treatment be submitted to 
auditory monitoring in order to confirm (or not) 
the findings of the present study.
Auditory monitoring by means of appropriate 
auditory tests, such as otoacoustic emission and 
high-frequency audiometry, should be initiated 
prior to ototoxic medication use. Therefore, it 
is expected that auditory abnormalities can be 
detected as early as possible, thus contributing 
to the maintenance of one of the most important 
human representations, which is communication.
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population resorts to the use of medications (other 
than those used for the treatment of tuberculosis) 
more often and that multisensory deficits and 
systemic diseases are more common among them; 
in addition, it is necessary to mention the fact 
that most patients had poor health status, which 
required hospital care.(10) All these factors should 
be considered at the time of the evaluation of 
the auditory/vestibular complaints, especially 
dizziness. The findings of the present study were 
similar to those reported by Carmo et al.,(10) who 
evaluated elderly individuals and found that the 
most common complaint was tinnitus, followed 
by common reports of dizziness.
In the present study, the sociodemographic 
and clinical characteristics of the study population 
were similar to those described in patients treated 
at referral hospitals for tuberculosis in Brazil.(7,9,12) 
There was a high proportion of male patients, 
patients receiving second-line medications, 
smokers, patients who consumed alcohol, and 
homeless individuals. Regarding gender, the 
results are similar to those found in the general 
population, hearing loss being more common 
among males, in both groups.
Exposure to noise is the factor that is most 
harmful to hearing in working adults.(13) In the 
present study, despite the high rate of exposure 
to noise in the workplace (55.2%), there was 
no association between exposure to noise and 
audiometric abnormalities. This association was 
not observed probably because we did not obtain 
precise information, either from patients or from 
medical charts, about sound intensity level or 
duration of exposure to noise.
In our study, the ototoxic medications 
used for the treatment of tuberculosis were 
streptomycin and amikacin, in accordance with the 
recommendations of the Brazilian National Ministry 
of Health for a standard second-line regimen.(2) 
Figure 2 - Mean auditory thresholds in group 1 (patients 
aged 18 to 40 years) and in group 2 (patients aged 
41 to 60 years).
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